Brazil to test new dengue fever vaccine

2013-09-26 23:13
Mosquitoes seemed to have changed their biting habits to skirt nets, a study has found. (AP)

Mosquitoes seemed to have changed their biting habits to skirt nets, a study has found. (AP)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Sao Paulo - Brazilian scientists will next month begin clinical tests on humans of a new vaccine against dengue fever, a leading Sao Paulo-based biomedical research institute said on Thursday.

The vaccine is being developed to combat the four closely related strains of dengue viruses that have been identified around the world, the Butantan institute said in a statement.

Brazil is frequently afflicted with the disease, which is spread by the mosquito Aedes aegypti.

Work on the vaccine began in 2005 in partnership with the US National Institutes of Health (NIH), Butantan said.

In a first phase, the vaccine was tested on animals and humans in the United States and produced a good immunological response, it noted.

The second phase is to begin in October with clinical tests on 300 Brazilian volunteers, all healthy adults aged between 18 and 59 of both sexes, over a five-year period.

The institute said the vaccine is expected to be ready by 2018.

Major advance

"This new phase is very important because it will be adapted to the particular characteristics of the Brazilian population," said Butantan Director Jorge Kalil.

"The production of a Brazilian vaccine for dengue fever is a major advance for public health," said Sao Paulo state health secretary Giovanni Guido Cerri.

"We are making major strides toward producing a safe, effective and low-cost vaccine which can be incorporated into the National Immunisation Program and meet the entire Brazilian demand."

Dengue fever affects between 50 and 100 million people in the tropics and subtropics each year, causing fever, muscle and joint ache as well as potentially fatal dengue hemorrhagic fever and dengue shock syndrome.

Researchers estimate that around three billion people in the world live in regions susceptible to dengue contagion and another 20 million tourists pass through them.

Butantan, which has a long tradition of research on snakes and poisonous animals, is the leading domestic producer of anti-venom sera and vaccines.

Read more on:    brazil  |  health  |  research

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
1 comment
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.